-
1
-
-
0035313918
-
Methods used to assess pulmonary deposition and absorption of drugs
-
Mobley C, Hochhaus G. Methods used to assess pulmonary deposition and absorption of drugs. DDT. 2001;6:367-375.
-
(2001)
DDT
, vol.6
, pp. 367-375
-
-
Mobley, C.1
Hochhaus, G.2
-
2
-
-
0035721547
-
Flunisolide HFA vs. flunisolide CFC: Pharmacokinetic comparison in healthy volunteers
-
Nolting A, Sista S, Abramowitz W. Flunisolide HFA vs. flunisolide CFC: pharmacokinetic comparison in healthy volunteers. Biopharm Drug Dispos. 2001;22:373-382.
-
(2001)
Biopharm Drug Dispos
, vol.22
, pp. 373-382
-
-
Nolting, A.1
Sista, S.2
Abramowitz, W.3
-
3
-
-
0037203699
-
In vitro and in vivo aspects of quantifying intrapulmonary deposition of a dry powder radioaerosol
-
Bondesson E, Asking L, Borgstrom L, et al. In vitro and in vivo aspects of quantifying intrapulmonary deposition of a dry powder radioaerosol. Int J Pharm. 2002;232:149-156.
-
(2002)
Int J Pharm
, vol.232
, pp. 149-156
-
-
Bondesson, E.1
Asking, L.2
Borgstrom, L.3
-
4
-
-
0032821388
-
Dose-proportional pharmacokinetics of budesonide inhaled via Turbuhaler®
-
Kaiser H, Aaronson D, Rockhorn R, et al. Dose-proportional pharmacokinetics of budesonide inhaled via Turbuhaler®. Br J Clin Pharmacol. 1999;48:309-316.
-
(1999)
Br J Clin Pharmacol
, vol.48
, pp. 309-316
-
-
Kaiser, H.1
Aaronson, D.2
Rockhorn, R.3
-
6
-
-
0030867287
-
Pharmacokinetics and dose proportionality of beclomethasone from three strengths of a CFC-free beclomethasone dipropionate metered-dose inhaler
-
Harrison LI, Dahl DR, Cline A, et al. Pharmacokinetics and dose proportionality of beclomethasone from three strengths of a CFC-free beclomethasone dipropionate metered-dose inhaler. Biopharm Drug Dispos. 1997;18:635-643.
-
(1997)
Biopharm Drug Dispos
, vol.18
, pp. 635-643
-
-
Harrison, L.I.1
Dahl, D.R.2
Cline, A.3
-
7
-
-
0034747709
-
In vitro and in vivo techniques used in drug development for evaluation of dose delivery of inhaled corticosteroids
-
Rhodes GR, Rohatagi S, Gillen MS, et al. In vitro and in vivo techniques used in drug development for evaluation of dose delivery of inhaled corticosteroids. J Clin Pharmacol. 2001;41:7-18.
-
(2001)
J Clin Pharmacol
, vol.41
, pp. 7-18
-
-
Rhodes, G.R.1
Rohatagi, S.2
Gillen, M.S.3
-
8
-
-
0034567438
-
Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma
-
Vanden Burgt JA, Busse WW, Martin RJ, et al. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma. J Allergy Clin Immunol. 2000;106:1209-1224.
-
(2000)
J Allergy Clin Immunol
, vol.106
, pp. 1209-1224
-
-
Vanden Burgt, J.A.1
Busse, W.W.2
Martin, R.J.3
-
9
-
-
0029972560
-
The inhalation device influences lung deposition and bronchodilating effect of terbutaline
-
Borgström L, Derom E, Ståhl E, et al. The inhalation device influences lung deposition and bronchodilating effect of terbutaline. Am J Respir Crit Care Med. 1996;153:1636-1640.
-
(1996)
Am J Respir Crit Care Med
, vol.153
, pp. 1636-1640
-
-
Borgström, L.1
Derom, E.2
Ståhl, E.3
-
10
-
-
0010451113
-
Rotary planar multi-dose powder inhaler
-
Corbett JS, Hart JL, Jansen R, et al. Rotary planar multi-dose powder inhaler. J Aerosol Med. 1993;6(suppl):72.
-
(1993)
J Aerosol Med
, vol.6
, Issue.SUPPL.
, pp. 72
-
-
Corbett, J.S.1
Hart, J.L.2
Jansen, R.3
-
11
-
-
0031833291
-
Discrepancy between in vitro and in vivo dose variability for a pressurized metered dose inhaler and a dry powder inhaler
-
Borgström L, Asking L, Beckman O, et al. Discrepancy between in vitro and in vivo dose variability for a pressurized metered dose inhaler and a dry powder inhaler. J Aerosol Med. 1998;11(suppl 1):S59-S64.
-
(1998)
J Aerosol Med
, vol.11
, Issue.1 SUPPL.
-
-
Borgström, L.1
Asking, L.2
Beckman, O.3
-
12
-
-
0031803408
-
New concepts for the variable flow rate: Andersen Cascade Impactor and calibration data
-
Nichols SC, Brown DR, Smurthwaite M. New concepts for the variable flow rate: Andersen Cascade Impactor and calibration data. J Aerosol Med. 1998;11(suppl 1):S133-S138.
-
(1998)
J Aerosol Med
, vol.11
, Issue.1 SUPPL.
-
-
Nichols, S.C.1
Brown, D.R.2
Smurthwaite, M.3
-
13
-
-
0342437435
-
In vitro evaluation of dry powder inhalers II: Influence of carrier particle size and concentration on in vitro deposition
-
Steckel H, Muller BW. In vitro evaluation of dry powder inhalers II: influence of carrier particle size and concentration on in vitro deposition. Int J Pharm. 1997;154:31-37.
-
(1997)
Int J Pharm
, vol.154
, pp. 31-37
-
-
Steckel, H.1
Muller, B.W.2
-
14
-
-
0031455263
-
Scintigraphic assessment of drug delivery from the Ultrahaler® dry powder inhaler
-
Pitcairn GR, Lim J, Hollingworth A, et al. Scintigraphic assessment of drug delivery from the Ultrahaler® dry powder inhaler. J Aerosol Med. 1997;10:295-306.
-
(1997)
J Aerosol Med
, vol.10
, pp. 295-306
-
-
Pitcairn, G.R.1
Lim, J.2
Hollingworth, A.3
|